Market closed

Omnicell/$OMCL

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Omnicell

Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.

Ticker

$OMCL

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

Fort Worth, United States

Employees

3,660

Website

www.omnicell.com

Omnicell Metrics

BasicAdvanced

$2B

-

-$0.39

0.82 -

Price and volume

Market cap

$2B

Beta

0.82

52-week high

$51.85

52-week low

$25.12

Average daily volume

505K

Financial strength

Current ratio

1.052

Quick ratio

0.867

Long term debt to equity

2.56

Total debt to equity

49.014

Interest coverage (TTM)

-5.39%

Management effectiveness

Return on assets (TTM)

-0.87%

Return on equity (TTM)

-1.46%

Valuation

Price to revenue (TTM)

1.823

Price to book

1.59

Price to tangible book (TTM)

6.51

Price to free cash flow (TTM)

16.407

Growth

Revenue change (TTM)

-10.26%

Earnings per share change (TTM)

-49.62%

3-year revenue growth (CAGR)

-0.19%

3-year earnings per share growth (CAGR)

-39.37%

What the Analysts think about Omnicell

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Omnicell stock.

Omnicell Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Omnicell Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Omnicell News

AllArticlesVideos

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

Business Wire·1 day ago

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire·6 days ago

Omnicell Announces OmniSphere

Business Wire·1 month ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OMCL

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Omnicell stock?

Omnicell (OMCL) has a market cap of $2B as of January 15, 2025.

What is the P/E ratio for Omnicell stock?

The price to earnings (P/E) ratio for Omnicell (OMCL) stock is 0 as of January 15, 2025.

Does Omnicell stock pay dividends?

No, Omnicell (OMCL) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Omnicell dividend payment date?

Omnicell (OMCL) stock does not pay dividends to its shareholders.

What is the beta indicator for Omnicell?

Omnicell (OMCL) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.